小児性ソーリアシスにおける狭帯紫外線 (ナローバンドUVB) の後,再発のない期間を予測する現実世界の予測:多センター研究

Berna Solak¹, Burhan Engin², Zeynep Güngör³

¹Department of Dermatology, Faculty of Medicine, Sakarya University, Sakarya, Türkiye.

Photodermatology, photoimmunology & photomedicine

|February 12, 2026

まとめ

狭帯紫外線B (NB-UVB) フォトセラピーが小児性ソーリアーシスに有効ですが,再発は一般的です. 局所用コルチコステロイドの使用は寛解を延ばし,爪の関与は再発のリスクが高いことを示します.

科学分野:

皮膚科皮膚科について
フォトセラピーによる照明療法
小児医学は,小児科の医学である.

背景:

狭帯紫外線B (NB-UVB) フォトセラピーは,小児性の治療法として認められており,安全性と有効性があります.
しかし,治療後の再発率が高いことが大きな課題であり,小児の寛解期間に影響を与える要因に関するデータは限られている.

研究の目的:

NB-UVB光療法を受ける小児性ソーリアーシス患者の治療結果,再発パターン,持続的な寛解の予測要因を評価する.
具体的には,ナイル関わりなどの臨床指標とともに,局所用コルチコステロイドとカルシポトリオールの同時使用の影響を調査します.

主な方法:

6つのトルコの皮膚科センターでNB-UVBで治療された114人の小児性ソーリアーシス患者を対象とした多センター遡及研究.
治療への反応は,少なくとも75%の改善をPsoriasis Area and Severity Index (PASI75) で達成すると定義されました.
再発は,治療後6ヶ月以内に有意な再発として特定され,さらなる介入が必要になりました.

主要な成果:

ほとんどの患者 (65.8%) がPASI75を達成し,42.1%がPASI90.0を達成しました. 回答者は,より高い累積的なNB-UVB用量とより多くの治療セッションを受けた.
再発は,6ヶ月以内に回答者の24.0%で発生しました. 同時に局所用コルチコステロイドを使用すると,再発のない期間が長くなる (p=0.001),指甲の関与はより短い寛解を予測する (p=0.002).
局所カルシポトリオールと疾患サブタイプは,再発を有意に予測しなかった. NB-UVBは好ましい安全性プロファイルを示し,最も一般的な副作用は軽度の赤血腫とである.

結論:

NB-UVB光療法は,小児性ソーリアーシスに対する高い有効性と良好な安全性プロファイルを示しています.
同時に局所用コルチコステロイドを使用すると,寛解期間が延長される可能性があります. 爪の関わりは,再発リスクの増加の重要な指標として機能し,より密接な患者のモニタリングと調整されたメンテナンス戦略を保証します.

キーワード:

爪の絡み爪の絡み狭帯紫外線 (UVB) は,狭帯の紫外線である.小児性ソーリアーシスフォトセラピーによる光療法です.再発が再発する.局所用コルチコステロイド

さらに関連する動画

02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

945

08:05

A Procedure to Study Stress-Induced Relapse of Heroin Seeking after Punishment-Imposed Abstinence

Published on: March 23, 2022

3.1K

関連する概念動画

01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

279

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

279

01:14

Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship

For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...

01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

334

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...

334

01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

247

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

247

01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...

01:27

Real Number System

1.2K

The real number system includes all numbers used for counting, measuring, and comparing quantities. Natural numbers are the basic counting numbers: 1, 2, 3, and so on. Integers expand this set by including zero and negative whole numbers: ..., –3, –2, –1, 0, 1, 2, .... Rational numbers are those that can be expressed as the ratio of two integers m/n, where n≠0. This includes fractions like 1/2, integers such as 46, and decimals that terminate, such as 0.17, or...